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t was 1958 when von Graefe 1 , Verhoeff and Waite 2 defined spontaneous serous detachment of choroid. In 1963, Schepens and Brockhurst 3 coined the term "uveal effusion". They reported spontaneous exudative detachment of choroid and ciliary body. In 1982, Gass and Jallow introduced the term "idiopathic uveal effusion syndrome" (UES) to describe idiopathic serous detachment of choroid, ciliary body and retina 4 . It is a rare ocular disorder affecting predominantly healthy young males and involvement is commonly bilateral. Albumin in the choroidal capillaries draws fluid into blood vessels and maintains relative dehydration of the Suprachoroidal space. Fenestrated capillaries of the choroid allow albumin to escape into the extra vascular space. To maintain the colloid osmotic gradient, albumin leaves the choroid across the sclera and this trans-scleral protein flow is facilitated by intraocular pressure. This equilibrium is disturbed by neoplastic and inflammatory diseases leading to accumulation of protein, mostly albumin, in the extra vascular space of the choroid. The higher colloid osmotic pressure reduces movement of fluid from the Suprachoroidal space into the choroidal capillaries leading to accumulation in Suprachoroidal fluid and serous ciliochoroidal effusion. Scleral thickness, scleral I Pak J Ophthalmol composition and the number of scleral emissary channels obstructs diffusion of protein out of eye, reduces aqueous flow through uveo-scleral outflow and vortex vein compression in nanophthalmic eyes leading to osmotic pressure gradient, which causes fluid accumulation in the Subretinal space, resulting in secondary serous retinal detachment. It is a diagnosis of exclusion. The clinical features are nonrhegmatogenous retinal detachment (RD) with marked shifting fluid. Retinal detachment often begins inferiorly like other exudative detachments. Fluid accumulation is always more anteriorly because anterior fibers attaching choroid to sclera are long and tangentially oriented whereas posterior fibers are short 5 . Other features are dilated episcleral vessels, blood in canal of schlemm, normal intraocular pressure (IOP), elevation of sub retinal fluid protein levels and elevated levels of cerebrospinal fluid (CCF) proteins. Striking changes may be evident at level of retinal pigment epithelium with so called "leopard spot" hyper pigmentation 3 . There is no evidence of intraocular inflammation except from few vitreous cells, which are present occasionally 3 . The natural history of disease is usually prolonged with remission and without treatment; patients may experience permanent loss of vision. The milder forms usually resolve but visual prognosis for eyes presenting with bullous retinal detachment is poor 6 .
Jackson et al revealed that UES can be associated with reduced trans-scleral albumin permeability. 7 It is divided into 3 types: Type 1 is nanophthalmic eyes and high hyperopic patients. Type 2 is nonnanophthalmic eyes with abnormal sclera, normal eyeball and small refractive errors. Type 3 is nonnanophthalmic eye with normal sclera. Nanophthalmic eyes plus presence of clinically detectable thickened and rigid sclera is a good predictor for histological abnormal sclera and provides good response to surgery 8 . Trelstad et al found that in uveal effusion syndrome, the sclera showed histo-chemical abnormalities: The bundles of collagen fibers in the sclera had a markedly irregular arrangement and varied in width. They also noted abnormal deposition of glycosaminoglycan among the collagen bundles. 9 The diagnostic value of FFA and ICGA and OCT is limited in uveal effusion syndrome and serves mostly to exclude other etiologies. Spectraldomain optical coherence tomography may show focal thickening of the retinal pigment epithelium layer corresponding to the areas of leopard spots 10 .
It responds poorly to medical treatment like corticosteroids and anti metabolites 4 and non-surgical treatment. Medical therapy has been described as a possible first step before surgical approach and includes topical prostaglandin analogs and/or oral carbonic anhydrase inhibitors 11, 12 . Although Brockhurst described good surgical results with decompression of vortex veins, but limitations like difficulty to isolate the veins and vein rupture made this procedure complicated and so was not preferred 13 . Successful surgeries, with no risk/damage to vortex vein, like use of Express Shunt for choroidal drainage in UES has also been documented 14 .
Uyama et al. reported that a small sclerectomy under the scleral flap could be effective in both type 1 and type 2 UES because the abnormal sclera and increased resistance to the trans-scleral outflow of intraocular fluid are thought to be the main causes of these disorders . 1 The full-thickness drainage sclerectomy resulted in resolution of UES, including type 3 UES, and a subsequent improvement in visual acuity. The effect may come from indirect decompression of vortex veins by relaxing scleral tension 15 . Some reports have shown that 10 mg dexamethasone given intravenous (IV) prior to surgery also improves the surgical outcome. A recent report showed that combining IV steroids with partial thickness sclerectomies yielded excellent anatomic results. The final visual gains were moderate in this report 16 .
Response to surgical options like scleral buckling and pars plana vitrectomy (PPV) is also not convincing. Successful retinal re-attachment of nonrhegmatogenous retinal detachment requires a scleral thinning procedure, including quadrantic partial thickness sclerectomies. The purpose of this case series was to study the effect of partial thickness sclerectomy in patients with idiopathic uveal effusion syndrome.
MATERIALS AND METHODS
Over the period of five years, six eyes of four patients (2 males and 2 females) with bilateral idiopathic uveal syndrome were included in study. The diagnosis was clinical. They had no evidence of posterior scleritis, orbital inflammatory disease, arteriovenous fistula, recent pan retinal photocoagulation, retinal surgery, recent ocular trauma, ocular neoplasm or drug reaction to sulfonamides or acetazolamide.
The surgical procedure included 360 degrees peritomy, followed by partial thickness sclerctomies measuring 4 x 6 mm placed in between the recti muscles. The sclerectomies were performed in all quadrants with the anterior border just anterior to the insertion of the recti muscles. All patients were followed up for one week, three weeks and twelve weeks postoperatively.
Case 1
A young male presented with gradual decrease in vision (perception of light) for last 6 months. His intraocular pressure (IOP) was 10 mmHg in both eyes. Quadrantic sclerectomies were done in both eyes with 1 week interval. Subretinal fluid (SRF) was drained in left eye but not in right eye. Hypotony was overcome in left eye with intravitreal C3F8 injection after SRF drainage. He showed progressive vision improvement over 3 months and his exudative retinal detachment also improved over 12 weeks.
Case 2
A young female presented with gradual decrease in visual acuity for last 9 months. Her visual acuity was light perception (PL) both eyes and IOP was 8 mmHg in right and 6 mm Hg in left eye respectively. She was wearing hypermetropic glasses of +7 DS in both eyes. Her axial length was 19 mm in both eyes. Her right eye was operated with quadrantic sclerectomies, her vision improved in that eye. She was advised same surgical procedure for the left eye but she did not report back for left eye surgery after 2 follow up visits.
Case 3
A 28 years old young lady with bilateral pseudophakia, presented with decreased vision, (counting fingers OD and 6/60 OS). Her record showed IOL power was +33 diopters OD and +36 diopters OS. She was under-corrected per-operatively with a residual post operative refractive error of + 8 D and +10 D glasses. Axial length was 18 mm in both eyes. IOP was recorded as 15 mmHg on presentation. She had bilateral exudative retinal detachment on B scan.
She underwent bilateral quadrantric sclerectomies under general anesthesia.
Case 4
A 26 years old male presented in OPD with gradual decrease in vision. His vision was 6/60 OD and 6/12 OS. IOP was 26 mm Hg OD and 18 mm Hg OS. Axial length was 18.14 mm OD and 18.03 mm OS. CD ratio was 0.2 in both eyes. Auto refractometer showed hypermetropia of +18 D and +18.5 D. On B scan 360 degrees choroidal detachment was observed in right eye. Left eye was normal.
RESULTS
Six eyes of four patients were operated and quadrantic sclerectomies was performed in these. The results are shown in table 1. 
DISCUSSION
There are multiple treatment modalities used for treatment of uveal effusion syndrome. Some ophthalmologists tried medical treatment for uveal effusion syndrome with oral steroid. Shield et al treated 104 eyes of uveal effusion syndrome with corticosteroids 17 Bausili et al used CO2 laser 18 and control was achieved in 95% cases in reports but according to others, surgical treatment was only effective option for treatment of idiopathic uveal effusion syndrome. We have found that surgical sclerectomies using partial thickness resection was very effective. We operated 6 eyes of 4 patients with idiopathic uveal effusion syndrome. Four Quadrant sclerectomies in 5 eyes and 2 quadrant sclerectomies in the 6 th eye was successful in attaining retinal reattachment. Following partial scleral resection all 6 eyes showed improvement in visual acuity. It was comparable with other studies done at other centers in London, USA and Bangladesh 19, 20, 21 .
Theories regarding pathogenesis of uveal effusion syndrome suggest that it is more common in nanophthalmic eyes 11 where scleral pathology is congenital and abnormally thick sclera compresses vortex veins leading to impeded drainage. Similarly, thick sclera is also seen in patients suffering from glycogen storage disease, mucopolysaccharidosis (Hunter syndrome) where sclera is thick due to increased deposition of mucopolysaccharides. Gass attempted vortex vein decompression in a series of eyes and found that full thickness scleral incisions were effective in causing retinal re-attachment, supporting the hypothesis that it was primarily scleral thickening causing uveal effusion by a barrier effect to diffusion of extra vascular protein (albumin is major protein) out of sclera and obstruction of vortex veins. Abnormal scleral composition increases resistance to transcleral protein outflow, which in turn leads to accumulation of protein in extra vascular space of choroid causing higher colloidal osmotic pressure. Prostaglandin analogs and steroids have been tried with varying success. Surgical management also has various modifications and is usually successful although visual results are moderate. Choroidal effusion and non rhegmatogenous retinal detachment can be successfully treated in patients with uveal effusion syndrome by quadrantic partial thickness sclerectomies 20, 21 . The disappearance of serous fluid after partial thickness sclerectomies is consistent with hypothesis that abnormally thick sclera prevents outflow of protein and suggests that removal of excess extra vascular protein may be improved by reducing scleral thickness and resistance to fluid outflow. Vortex vein decompression as a possible mechanism of uveal effusion in nanophthalmic eyes following glaucoma filtration surgery was first suggested by Schaffer in 1975 22 . In 1980, Brockhurst reported successful use of scleral thinning procedure with vortex vein decompression in treatment of nanophthalmic ciliochoroidal effusion 23 . Another case of bilateral UES was reported where the surgeon combined partial thickness scleral flaps with full thickness sclerectomies and reporting stable anatomic and visual results in the follow up period 24, 25 .
Limitation of our study was the small number of cases. Large scale studies need to be conducted to further compare different surgical techniques. We also recommend that surgeons need to review the available literature before contemplating any specific surgical procedure for this rare condition.
CONCLUSION
Given that UES is a very rare disorder, we still do not have clear guidelines regarding its complete management. Partial thickness sclerectomy is an effective treatment option for patients of uveal effusion syndrome not responding to medical treatment.
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